LUMO
Lumos Pharma, Inc. Common Stock
LUMO
LUMO
Delisted
LUMO was delisted on the 11th of December, 2024.
87 hedge funds and large institutions have $19.5M invested in Lumos Pharma, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 18 increasing their positions, 25 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
43% less capital invested
Capital invested by funds: $34M → $19.5M (-$14.5M)
Holders
87
Holding in Top 10
–
Calls
$35K
Puts
$34K
Top Buyers
| 1 | +$1.1M | |
| 2 | +$429K | |
| 3 | +$413K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$195K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$136K |
Top Sellers
| 1 | -$1.15M | |
| 2 | -$614K | |
| 3 | -$593K | |
| 4 |
BlackRock
New York
|
-$585K |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$490K |